Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Antimicrobial Agents and Chemotherapy|June 20, 2007
Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillinCornelia B Landersdorfer, Carl M J Kirkpatrick, Martina Kinzig-Schippers, et al.
The Journal of Infectious Diseases|August 4, 2007
Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plagueHenry S Heine, Arnold Louie, Fritz Sorgel, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Evaluation by monte carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteersWolfgang A Krueger, Jurgen Bulitta, Martina Kinzig-Schippers, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?Martina Kinzig-Schippers, Dorota Tomalik-Scharte, Alexander Jetter, et al.
Diagnostic Microbiology and Infectious Disease|September 21, 2010
Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulationLois S Lee, Martina Kinzig-Schippers, Anne N Nafziger, et al.
European Journal of Clinical Pharmacology|January 30, 2004
Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposureAlexander Jetter, Martina Kinzig-Schippers, Michael Illauer, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plagueHenry S Heine, Arnold Louie, Jeffrey J Adamovicz, et al.
European Journal of Clinical Pharmacology|March 27, 2004
Cytochrome P450 2C9 phenotyping using low-dose tolbutamideAlexander Jetter, Martina Kinzig-Schippers, Andreas Skott, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2006
Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicityUwe Fuhr, Melanie I Boettcher, Martina Kinzig-Schippers, et al.
Pageof 2